These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29222866)

  • 21. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
    Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
    Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation.
    Cole RT; Gandhi J; Bray RA; Gebel HM; Yin M; Shekiladze N; Young A; Grant A; Mahoney I; Laskar SR; Gupta D; Bhatt K; Book W; Smith A; Nguyen D; Vega JD; Morris AA
    J Heart Lung Transplant; 2018 Apr; 37(4):503-512. PubMed ID: 29198929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
    Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
    Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
    Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
    Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
    Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
    Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.
    Clerkin KJ; Restaino SW; Zorn E; Vasilescu ER; Marboe CC; Mancini DM
    J Heart Lung Transplant; 2016 Sep; 35(9):1059-66. PubMed ID: 27423693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.
    Kfoury AG; Hammond ME; Snow GL; Drakos SG; Stehlik J; Fisher PW; Reid BB; Everitt MD; Bader FM; Renlund DG
    J Heart Lung Transplant; 2009 Aug; 28(8):781-4. PubMed ID: 19632573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.
    Coutance G; Ouldamar S; Rouvier P; Saheb S; Suberbielle C; Bréchot N; Hariri S; Lebreton G; Leprince P; Varnous S
    J Heart Lung Transplant; 2015 Aug; 34(8):1050-7. PubMed ID: 25956740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature.
    Wozniak LJ; Naini BV; Hickey MJ; Bhattacharyya S; Reed EF; Busuttil RW; Farmer DG; Vargas JH; Venick RS; McDiarmid SV
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27597379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Wozniak LJ; Hickey MJ; Venick RS; Vargas JH; Farmer DG; Busuttil RW; McDiarmid SV; Reed EF
    Transplantation; 2015 Jul; 99(7):1416-22. PubMed ID: 26038872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
    Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
    Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
    Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Socioeconomic position and graft failure in pediatric heart transplant recipients.
    Singh TP; Gauvreau K; Bastardi HJ; Blume ED; Mayer JE
    Circ Heart Fail; 2009 May; 2(3):160-5. PubMed ID: 19808335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.
    Revelo MP; Miller DV; Stehlik J; Brunisholz K; Drakos S; Gilbert EM; Everitt M; Budge D; Alharethi R; Snow G; Hammond EH; Kfoury AG
    Cardiovasc Pathol; 2012; 21(6):445-54. PubMed ID: 22381397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
    J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.
    Kfoury AG; Stehlik J; Renlund DG; Snow G; Seaman JT; Gilbert EM; Stringham JS; Long JW; Hammond ME
    J Heart Lung Transplant; 2006 Nov; 25(11):1277-82. PubMed ID: 17097489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes.
    Thrush PT; Pahl E; Naftel DC; Pruitt E; Everitt MD; Missler H; Zangwill S; Burch M; Hoffman TM; Butts R; Mahle WT
    J Heart Lung Transplant; 2016 Dec; 35(12):1497-1504. PubMed ID: 27431753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluctuations in circulating endothelial progenitor cell levels and acute cardiac graft rejection.
    Rywik TM; Braniewska A; Kowalik I; Firczuk M; Kozar-Kamińska K; Wojciechowska A; Kasprzyk-Pawelec A; Sobieszczańska-Małek M; Leszek P; Rozentryt P; Zieliński T
    Pol Arch Intern Med; 2019 Dec; 129(12):889-897. PubMed ID: 31777401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.